VOR - NASDAQ

Vor Biopharma Inc.

VOR·NASDAQ

$13.44

-0.037%

HealthcareBiotechnology

Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AML blood cancer cells. The company's eHSCs targeted therapies, such as CAR-Ts, bispecific antibodies, and antibody-drug conjugates provide treatment for blood cancers. Vor Biopharma, Inc. has a collaboration agreement with Akron BioProducts to develop and manufacture cGMP nucleases. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$92.12M

EPS-70.5000

P/E Ratio-0.19

Earnings Date08/11/2026

vor

Total Current Assets

Last Annual Value

458.11M

3-Year CAGR

25%

5-Year CAGR

56%

10-Year CAGR

86%

Adjust for Inflation

Vor Biopharma Inc. Competitors Analysis of Total Current Assets

VOR · NASDAQ

Company	Total Current Assets	CAGR 3Y	CAGR 5Y	CAGR 10Y
Vor Biopharma Inc. NASDAQ:VOR	458.11M	48.2%	16.4%	N/A
Forte Biosciences, Inc. NASDAQ:FBRX	80.59M	28.1%	13.6%	9.5%
Spero Therapeutics, Inc. NASDAQ:SPRO	67.29M	-20.0%	-15.7%	18.9%
Codexis, Inc. NASDAQ:CDXS	96.82M	1.2%	-9.8%	13.5%
Coherus Oncology, Inc. NASDAQ:CHRS	206.71M	-24.3%	-19.3%	5.2%
Corbus Pharmaceuticals Holdings, Inc. NASDAQ:CRBP	166.95M	92.1%	10.7%	25.4%
Genelux Corporation NASDAQ:GNLX	15.13M	-14.5%	21.0%	N/A
Heron Therapeutics, Inc. NASDAQ:HRTX	238.07M	8.0%	-1.3%	14.4%
OmniAb, Inc. NASDAQ:OABI	65.34M	-11.7%	23.7%	N/A
Orchestra BioMed Holdings, Inc. NASDAQ:OBIO	107.91M	6.6%	57.0%	N/A
Protara Therapeutics, Inc. NASDAQ:TARA	159.50M	32.4%	11.4%	14.1%

Vor Biopharma Inc. Fair Value Envelope

VOR · NASDAQ

Our analysis suggests that VOR has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $13.44, this represents a potential HIDDEN relative to our calculated worth for Vor Biopharma Inc..

HIDDEN

Intrinsic Value

Current Price: $13.44

Related Guides

Blog Categories

Continue your VOR research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.